• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪组织功能障碍、维生素 D 缺乏与非酒精性脂肪性肝病发病机制的关系。

Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.

机构信息

Flavia A Cimini, Ilaria Barchetta, Maria-Gisella Cavallo, Laura Bertoccini, Marco G Baroni, Department of Experimental Medicine, Sapienza University of Rome, 00128 Rome, Italy.

出版信息

World J Gastroenterol. 2017 May 21;23(19):3407-3417. doi: 10.3748/wjg.v23.i19.3407.

DOI:10.3748/wjg.v23.i19.3407
PMID:28596677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5442077/
Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. Its pathogenesis is complex and not yet fully understood. Over the years many studies have proposed various pathophysiological hypotheses, among which the currently most widely accepted is the "multiple parallel hits" theory. According to this model, lipid accumulation in the hepatocytes and insulin resistance increase the vulnerability of the liver to many factors that act in a coordinated and cooperative manner to promote hepatic injury, inflammation and fibrosis. Among these factors, adipose tissue dysfunction and subsequent chronic low grade inflammation play a crucial role. Recent studies have shown that vitamin D exerts an immune-regulating action on adipose tissue, and the growing wealth of epidemiological data is demonstrating that hypovitaminosis D is associated with both obesity and NAFLD. Furthermore, given the strong association between these conditions, current findings suggest that vitamin D may be involved in the relationship between adipose tissue dysfunction and NAFLD. The purpose of this review is to provide an overview of recent advances in the pathogenesis of NAFLD in relation to adipose tissue dysfunction, and in the pathophysiology linking vitamin D deficiency with NAFLD and adiposity, together with an overview of the evidence available on the clinical utility of vitamin D supplementation in cases of NAFLD.

摘要

非酒精性脂肪性肝病(NAFLD)是全球最常见的慢性肝病。其发病机制复杂,尚未完全阐明。多年来,许多研究提出了各种病理生理假说,其中目前最广泛接受的是“多重平行打击”理论。根据该模型,肝细胞内脂质堆积和胰岛素抵抗增加了肝脏对许多协同作用的因素的易感性,这些因素共同促进肝损伤、炎症和纤维化。在这些因素中,脂肪组织功能障碍和随后的慢性低度炎症起着关键作用。最近的研究表明,维生素 D 对脂肪组织具有免疫调节作用,越来越多的流行病学数据表明,维生素 D 缺乏症与肥胖和 NAFLD 都有关。此外,鉴于这些情况之间存在很强的关联,目前的研究结果表明,维生素 D 可能参与了脂肪组织功能障碍与 NAFLD 之间的关系。本文综述了与脂肪组织功能障碍相关的 NAFLD 发病机制、维生素 D 缺乏与 NAFLD 和肥胖症之间的病理生理学联系的最新进展,以及维生素 D 补充治疗 NAFLD 的临床应用证据概述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc78/5442077/a7f3d511dd22/WJG-23-3407-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc78/5442077/a7f3d511dd22/WJG-23-3407-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc78/5442077/a7f3d511dd22/WJG-23-3407-g001.jpg

相似文献

1
Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.脂肪组织功能障碍、维生素 D 缺乏与非酒精性脂肪性肝病发病机制的关系。
World J Gastroenterol. 2017 May 21;23(19):3407-3417. doi: 10.3748/wjg.v23.i19.3407.
2
Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update.维生素 D 与代谢相关脂肪性肝病(MAFLD):最新进展。
Nutrients. 2020 Oct 28;12(11):3302. doi: 10.3390/nu12113302.
3
Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease.脂肪组织功能障碍及其在非酒精性脂肪性肝病发病机制中的作用的最新进展。
Cells. 2021 Nov 25;10(12):3300. doi: 10.3390/cells10123300.
4
Vitamin D: a new player in non-alcoholic fatty liver disease?维生素D:非酒精性脂肪性肝病中的新角色?
World J Gastroenterol. 2015 Feb 14;21(6):1718-27. doi: 10.3748/wjg.v21.i6.1718.
5
Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis.维生素 D 与非酒精性脂肪性肝炎的胰岛素抵抗及疾病严重程度的关系。
J Hepatol. 2015 Feb;62(2):405-11. doi: 10.1016/j.jhep.2014.08.040. Epub 2014 Sep 6.
6
A narrative review on effects of vitamin D on main risk factors and severity of Non-Alcoholic Fatty Liver Disease.关于维生素D对非酒精性脂肪性肝病主要危险因素及严重程度影响的叙述性综述。
Diabetes Metab Syndr. 2019 May-Jun;13(3):2260-2265. doi: 10.1016/j.dsx.2019.05.013. Epub 2019 May 22.
7
Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的病理生理学。
Clin Liver Dis. 2018 Feb;22(1):23-37. doi: 10.1016/j.cld.2017.08.007. Epub 2017 Oct 18.
8
Glucocorticoids and non-alcoholic fatty liver disease.糖皮质激素与非酒精性脂肪性肝病
J Steroid Biochem Mol Biol. 2015 Nov;154:94-103. doi: 10.1016/j.jsbmb.2015.07.020. Epub 2015 Aug 1.
9
Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease.维生素D缺乏与全身脂肪量增加及非酒精性脂肪性肝病的更严重程度相关。
Liver Int. 2014 Jul;34(6):e118-27. doi: 10.1111/liv.12312. Epub 2013 Oct 1.
10
Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.非酒精性脂肪性肝病与肥胖:生化、代谢及临床表现
World J Gastroenterol. 2014 Jul 28;20(28):9330-7. doi: 10.3748/wjg.v20.i28.9330.

引用本文的文献

1
Relationship between level of serum VIT D and insulin resistance in patients with MAFLD.MAFLD患者血清维生素D水平与胰岛素抵抗的关系。
BMC Endocr Disord. 2025 Jul 14;25(1):176. doi: 10.1186/s12902-024-01820-0.
2
Prognostic value of atherogenic index of plasma on the all-cause and causes-specific mortality among patients with metabolic dysfunction-associated steatotic liver disease.血浆致动脉粥样硬化指数对代谢功能障碍相关脂肪性肝病患者全因死亡率和特定病因死亡率的预后价值。
Diabetol Metab Syndr. 2025 Jun 14;17(1):212. doi: 10.1186/s13098-025-01800-x.
3
Role of 1,25-dihydroxyvitamin D in alleviating hepatic steatosis: Targeting M1 macrophage polarization in non-alcoholic fatty liver disease.

本文引用的文献

1
Vitamin D limits inflammation-linked microRNA expression in adipocytes in vitro and in vivo: A new mechanism for the regulation of inflammation by vitamin D.维生素 D 限制了体外和体内脂肪细胞中与炎症相关的 microRNA 表达:维生素 D 调节炎症的新机制。
Epigenetics. 2018;13(2):156-162. doi: 10.1080/15592294.2016.1276681. Epub 2018 Mar 7.
2
Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial.能量限制饮食后每日补充骨化三醇加或不加钙对非酒精性脂肪性肝病患者疾病缓解的影响:随机、对照、双盲试验。
Clin Nutr. 2017 Dec;36(6):1490-1497. doi: 10.1016/j.clnu.2016.09.020. Epub 2016 Sep 28.
3
1,25-二羟基维生素D在减轻肝脂肪变性中的作用:针对非酒精性脂肪性肝病中的M1巨噬细胞极化
World J Gastrointest Oncol. 2025 Mar 15;17(3):102424. doi: 10.4251/wjgo.v17.i3.102424.
4
Vitamin D Attenuates Non-Alcoholic Fatty Liver Disease in High-Fat Diet-Induced Obesity Murine Model.维生素D减轻高脂饮食诱导肥胖小鼠模型中的非酒精性脂肪性肝病
Yonsei Med J. 2025 Feb;66(2):75-86. doi: 10.3349/ymj.2024.0038.
5
Vitamin D 1,25-Dihydroxyvitamin D reduces lipid accumulation in hepatocytes by inhibiting M1 macrophage polarization.维生素D 1,25-二羟基维生素D通过抑制M1巨噬细胞极化减少肝细胞中的脂质积累。
World J Gastrointest Oncol. 2024 Dec 15;16(12):4685-4699. doi: 10.4251/wjgo.v16.i12.4685.
6
The Interplay between Liver and Adipose Tissue in the Onset of Liver Diseases: Exploring the Role of Vitamin Deficiency.肝脏和脂肪组织在肝脏疾病发病中的相互作用:探讨维生素缺乏的作用。
Cells. 2024 Sep 30;13(19):1631. doi: 10.3390/cells13191631.
7
The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review.抗氧化剂在代谢功能障碍相关脂肪性肝病治疗中的作用:一项系统评价
Antioxidants (Basel). 2024 Jun 29;13(7):797. doi: 10.3390/antiox13070797.
8
Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease.甘油三酯-葡萄糖相关指标与非酒精性脂肪性肝病或代谢相关脂肪性肝病患者死亡的相关性。
Cardiovasc Diabetol. 2024 Jul 4;23(1):232. doi: 10.1186/s12933-024-02343-7.
9
Serum Vitamin D Level in Overweight Individuals and Its Correlation With the Incidence of Non-alcoholic Fatty Liver Disease.超重人群血清维生素 D 水平及其与非酒精性脂肪肝病发生率的相关性。
Physiol Res. 2024 Apr 30;73(2):265-271. doi: 10.33549/physiolres.935164.
10
The Metabolic Impact of Nonalcoholic Fatty Liver Disease on Cognitive Dysfunction: A Comprehensive Clinical and Pathophysiological Review.非酒精性脂肪肝疾病对认知功能障碍的代谢影响:全面的临床和病理生理学综述。
Int J Mol Sci. 2024 Mar 15;25(6):3337. doi: 10.3390/ijms25063337.
No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.口服补充维生素D对2型糖尿病患者非酒精性脂肪性肝病无影响:一项随机、双盲、安慰剂对照试验
BMC Med. 2016 Jun 29;14:92. doi: 10.1186/s12916-016-0638-y.
4
Vitamin D Levels Are Inversely Associated with Liver Fat Content and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Middle-Aged and Elderly Population: The Shanghai Changfeng Study.维生素D水平与中国中老年人群肝脏脂肪含量及非酒精性脂肪性肝病风险呈负相关:上海长风研究
PLoS One. 2016 Jun 10;11(6):e0157515. doi: 10.1371/journal.pone.0157515. eCollection 2016.
5
Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Non-alcoholic Fatty Liver Disease: Possible Role for MAPK and NF-κB?维生素D缺乏与非酒精性脂肪性肝病成人非酒精性脂肪性肝炎风险增加相关:丝裂原活化蛋白激酶和核因子κB的潜在作用?
Am J Gastroenterol. 2016 Jun;111(6):852-63. doi: 10.1038/ajg.2016.51. Epub 2016 Mar 22.
6
Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: a cross-sectional study (Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT-China)).低维生素D水平与非酒精性脂肪性肝病:中国东部男性中两者独立关联的证据——一项横断面研究(中国东部代谢性疾病及危险因素患病率调查(SPECT-China))
Br J Nutr. 2016 Apr;115(8):1352-9. doi: 10.1017/S0007114516000386. Epub 2016 Feb 18.
7
Association between 25-hydroxyvitamin D and inflammatory biomarker levels in a cross-sectional population-based study, São Paulo, Brazil.巴西圣保罗一项基于人群的横断面研究中25-羟基维生素D与炎症生物标志物水平之间的关联
Nutr Res. 2016 Jan;36(1):1-8. doi: 10.1016/j.nutres.2015.10.006. Epub 2015 Oct 23.
8
Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss.非酒精性脂肪性肝病的治疗:医学、手术和内镜减肥的作用。
J Clin Transl Hepatol. 2015 Sep 28;3(3):230-8. doi: 10.14218/JCTH.2015.00019. Epub 2015 Sep 15.
9
Starring role of toll-like receptor-4 activation in the gut-liver axis.Toll样受体4激活在肠-肝轴中的主导作用。
World J Gastrointest Pathophysiol. 2015 Nov 15;6(4):99-109. doi: 10.4291/wjgp.v6.i4.99.
10
High-dose vitamin D supplementation and liver histology in NASH.非酒精性脂肪性肝炎中高剂量维生素D补充与肝脏组织学
Gut. 2016 Apr;65(4):717-8. doi: 10.1136/gutjnl-2015-310417. Epub 2015 Aug 20.